Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has released a corporate update regarding the company’s activities thus far this year; the update also provides a look at company expectations for the remainder of the year. Noting that since the eruption of COVID-19, businesses have been “thrust into a series of complex, unpredictable situations that have required adaptation, innovation, and a discipline to remain focused on key objectives,” the report observed that the global pandemic had impacted its HealthTab(TM) platform. HealthTab is Avricore’s turnkey point-of-care testing solution that features best-in-class point-of-care technologies and a secure, cloud-based platform. The update stated that the pilot project announced with Shoppers Drug Mart(R) had moved forward, and the company has seen incremental increases in the number of locations under this program; the update also reported that currently 53 locations were actively operating, with ongoing discussions with additional pharmacy groups to expand the Canadian and International HealthTab network. The company’s most recent financial numbers indicate fiscal 2021 saw a year-over-year 372% increase in revenues, and the company’s product development has focused on testing, developing and deploying several system improvements throughout the year. Specifically, Avricore has launched a fully upgraded platform, enhanced security for integration partners, added more flexible reporting options and developed a sector-leading QA program. “At the beginning of the year, we laid out a plan to expand our point-of-care testing platform in pharmacies across Canada and beyond and begin to generate more substantial revenues,” said Avricore Health CEO Hector Bremner in the press release. “Our progress towards those objectives has been significant, and we are very confident in our current client negotiations and planning.”
To view the full press release, visit https://ibn.fm/IYXRW
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab, a wholly owned subsidiary, the company’s mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, please visit www.AvricoreHealth.com
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
